. FDA OKs use of convalescent plasma for COVID-19 - IOPAC Press "Enter" to skip to content

FDA OKs use of convalescent plasma for COVID-19

Stephanie Soucheray | News Reporter | CIDRAP NewsAug 24, 2020Feds tout a 35% increase in survival, but the absolute improvement is closer to 3%, according to Mayo data.